9627.Se
The company operates in the healthcare sector, primarily engaged in pharmaceuticals and healthcare facilities and services.
Business. The company operates in the healthcare sector, primarily engaged in pharmaceuticals and healthcare facilities and services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare sector, primarily engaged in pharmaceuticals and healthcare facilities and services.
The company's capital structure shows a debt-to-equity ratio of 0.69, indicating a moderate level of leverage. However, the company's liquidity position is characterized by a current ratio of 1.44, suggesting it has sufficient short-term assets to cover its short-term liabilities. Despite this, the company's free cash flow is negative at -27.85 million, which may indicate challenges in generating sufficient cash from operations to fund its capital expenditures and other obligations.
Profitability metrics reveal a concerning trend, with a return on equity of -22.13% and a return on assets of -9.56%. These figures are significantly below the industry norms, indicating that the company is not effectively utilizing its equity and assets to generate profits. The operating income is negative at -7.08 million, and the net income is also negative at -10.32 million, further highlighting the company's financial distress.
The company's revenue is concentrated in a single segment, as disclosed in the financial snapshot, with no specific geographic breakdown provided. This lack of diversification may expose the company to higher risks if the segment faces any downturns. The absence of detailed segment and geographic data limits the ability to assess the company's exposure to different markets and potential revenue streams.
The company's growth trajectory is uncertain, with no specific numeric deltas provided for the current or next fiscal year. The negative operating and net income figures suggest that the company is not on a positive growth path and may require significant operational improvements or strategic changes to turn around its performance.
Risk factors include a medium liquidity risk, as indicated by the risk assessment, and a negative free cash flow, which could lead to liquidity constraints. The dilution risk is assessed as low, but the company's negative net cash position after subtracting total debt is a key flag that may impact its financial stability.
Recent events and filings have not been provided in the input data, so no specific recent developments can be cited. However, the financial snapshot and risk assessment suggest that the company is facing significant financial challenges that may require close monitoring and potential strategic interventions.
- The company is experiencing significant financial distress, as evidenced by negative operating and net income.
- The company's liquidity position is moderate, but its negative free cash flow is a concern.
- The company's profitability metrics are well below industry norms, indicating poor performance.
- The company's capital structure shows a moderate level of leverage, but the negative net cash position is a key risk.
- The company's growth trajectory is uncertain, with no clear direction provided for the current or next fiscal year.
- The company's lack of detailed segment and geographic data limits the ability to assess its market exposure and diversification.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 9627.SE Market data — financials · 2026-05-27